Pharma News

Early efficacy figures for Pfizer's COVID-19 vaccine are high, and NIAID Director Anthony Fauci said he hopes Moderna will provide similar data, but most of the new mRNA injections require stringent storage requirements, which add logistical hurdles to wi

• Covid 19 vaccine
• CureVac covid-19

Gilead’s remdesivir, now known as Veklury, is perhaps the most successful COVID-19 drug so far. It scored a full FDA nod in October after months of emergency use and brought in $873 million last quarter as the standard of care in hospitalized patients.

• Remdesivir trends
• Gilead COVID 19

Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for NVX-CoV2373

• Novavax covid 19
• Novavax vaccine

In a preliminary study of COVID-19 patients with mild-to-moderate disease who were attempting to recover in their homes

• Covid 19 vaccine
• covid 19 research

European Commission approved a fourth contract with pharmaceutical companies BioNTech and Pfizer, which provides for the initial purchase of 200 million doses on behalf of all EU Member States

• EU COVID-19 vaccine
• BioNTech vaccine
• pfizer covid 19

Medicago, a biopharmaceutical company headquartered in Quebec City, and GSK have announced the start of Phase 2/3 clinical trials of its plant-derived vaccine candidate for COVID-19 to evaluate its efficacy, safety, and immunogenicity.

• Medicago covid 19
• Covid 19 vaccine

Biotechnology company Moderna, Inc. a pioneer in messenger RNA (mRNA) therapeutics and vaccines that create the next generation of transformative medicines for patients

• Moderna covid-19
• moderna vaccine

Apatinib (Apa) is a small molecule targeted tumor therapy drug. Its main anti-tumor mechanism is to highly selectively bind and inhibit vascular endothelial cell growth factor receptor 2 (VEGFR-2), thereby reducing Tumor cell microvessel density

• apatinib research

Vitamin H is one of the B vitamins, also known as biotin, vitamin B7, coenzyme R (Coenzyme R), etc. It is an essential substance for the synthesis of vitamin C and an indispensable substance for metabolism.

• vitamin H
• vitamin B7

The diabetes drugs market is fragmented with hardly any significant and generic players. The market for insulin drugs and Sglt-2 drugs is dominated by several major players such as Novo-Nordisk, Sanofi, AstraZeneca and Bristol Myers Squibb.

• diabetes drug market
• sanofi diabetes

The global diabetes market has been growing steadily in recent years, with the global diabetes drug market reaching USD 83 billion in 2018 and is expected to exceed USD 124 billion by 2022.

• diabetes drug market
• diabete market trend

The drug target refers to the binding site of the drug in the human body. The key to the research and development of modern new drugs is to find and determine the target first.

• drug target
• EGFR

Introduction to hypoglycemic drugs: DPP-4, SGLT-2 & GLP-1

• antidiabetic drug
• DPP-4
• SGLT-2
• GLP-1

Introduction to hypoglycemic drugs: Metformin Hydrochloride, Thiazolidinedione & α-Glucosidase inhibitors

• hypoglycemic drug
• Metformin
• Thiazolidinedione

Insulinotropic agents are alternate first-line hypoglycemic agents, which are available as sulfonylureas as well as non-sulfonylureas.

• Insulinotropic agents

According to the recently released "2020 CMR Drug Development Assessment Report" by the Center for International Drug Research and Development (CMR)

• drug research
• china medicine market

The coronavirus vaccine is expected to be available within two months, according to pharmaceutical company AstraZeneca.

• Covid 19 vaccine
• AstraZeneca vaccine

Diabetes mellitus is a chronic, syndromic disorder of glucose metabolism caused by absolute or relative insufficiency of insulin, or decreased sensitivity of target cells to insulin

• Diabete cause
• diabetes treatment

China has made remarkable progress in rare disease care, as treatments have become available in China's market for most rare diseases, yet patients suffering from some rare diseases that require costly medication are still in need of more support

• covid 19 drug
• Covid 19 vaccine

The Kangmei Chinese medicinal material price index, a barometer of the traditional Chinese medicine (TCM) material market, rose 0.04 percent to 1,289.98 points Tuesday.

• Chinese medicinal material price